Customer Publication

Alpha-Amylase Inhibits Cell Proliferation and Glucose Uptake in Human Neuroblastoma Cell Lines

Authors: Pierzynowska et al.

Journal: BioMed Research International (2022)

Institution: Lund University

Research Areas: Cancer research

Cell Lines: SHSY5Y, LA-N-1 (human neuroblastoma cell lines)

Summary: This study describes effects of alpha-amylase (α-amylase) on human neuroblastoma (NB) cell lines. NB is the most common malignancy diagnosed in infants younger than 12 months. Some clinical observations revealed an inverse association between the risk of NB development and breastfeeding. Already in the beginning of the 20th century, α-amylase, which is present in breast milk, was shown to have anticancer properties. Data presented in this study shows that pancreatic α-amylase inhibits cell proliferation and directly impacts glucose uptake in the human NB cell lines. Changes in glucose metabolism are recognized as being one of the hallmarks of cancer. HoloMonitor M4 was used to monitor the effect of α-amylase on cell motility (speed, accumulated distance) and proliferation (direct cell count) of neuroblastoma cells. Time-lapse images were taken every 5 minutes for 72 hours to analyze kinetic motility and proliferation of single cells and prepare cell videos using the AppSuite software.

Keywords: HoloMonitor M4, cell proliferation, cell motility, neuroblastoma, alpha-amylase

Read the article …

Phase Holographic Imaging PHI AB
Skiffervägen 48
224 78 Lund
Sweden
+46 46 38 60 80
info@phiab.se

Phase Holographic Imaging PHI Inc.
265 Franklin Street Suite 1702
Boston, MA 02110
USA
+1 617-963-5150
info@phiab.com

Invoicing

VAT: SE556542781101
faktura@phiab.se

Securities Identification

ISIN: SE0005504636
LEI: 549300JZR79QYESM6296

HoloMonitor® is a registered trademark
Copyright © 2012-2021
Phase Holographic Imaging PHI AB

Phase Holographic Image logo in white

PHI Theme 3.12.2